Toronto doctors have carried out a groundbreaking transplant with a heart that had stopped beating, according to the ...

TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the first patient has successfully completed dosing ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...

University Health Network (UHN) has completed Canada’s first heart transplant after death by circulatory criteria (DCC), ...

Canada's first heart transplant using a donor after circulatory death could boost transplants by 30 per cent, giving more patients a second chance at life.

First patient successfully completes dosing at Toronto General Hospital St. Michael’s Hospital is expected to be the next Canadian clinical site activated Arch is looking for additional clinical sites ...

With Toronto’s DCC heart transplant recipient 'recovering very well,' this process now 'opens the door' for more patients waiting for a 'life-saving' transplant, said Dr. Seyed Alireza Rabi, a cardiac ...

The CS-AKI Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide with a recruitment target of 240 patients. The primary objective of the ...

Toronto doctors have carried out a groundbreaking transplant with a heart that previously stopped beating, the University Health Network (UHN) says. In a news release Wednesday, UHN said the operation ...